SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-19-003959
Filing Date
2019-10-10
Accepted
2019-10-10 16:32:52
Documents
1
Group Members
DAVID JOHNSONKENNETH SHEA

Document Format Files

Seq Description Document Type Size
1 AMAG PHARMACEUTICALS, INC. p19-2049sc13da.htm SC 13D/A 59105
  Complete submission text file 0000902664-19-003959.txt   60783
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-38286 | Film No.: 191146449
SIC: 2834 Pharmaceutical Preparations

Mailing Address 520 MADISON AVENUE NEW YORK NY 10022
Business Address 520 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A